Anima signs new strategic collaboration deal with Takeda

Anima Biotech has announced its new strategic collaboration deal with Takeda Pharmaceutical Company for the discovery and development of new medicines to combat genetically defined neurological diseases. The

The post Anima signs new strategic collaboration deal with Takeda appeared first on Pharmaceutical Business review.

This is not a CAPTIS article. Originally, it was published here.